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Abstract 
An eight week old Labrador Retriever puppy presented with stiff-legged robotic gait. Abnormal gait was most evident after rest and 
improved with prolonged activity. On occasions, initiation of sudden movements would result in collapse with rigidity of the trunk and stiff 
extended limbs for several seconds. Other clinical signs were excitement-induced upper airway stridor and oropharyngeal dysphagia. Myotonia 
congenita was diagnosed based on clinical signs, abundant myotonic discharges on electromyography and exclusion of structural myopathies 
on histology. Whole exome sequencing revealed a case-specific homozygous variant in CLCN1 , c.2275A > T resulting in a premature stop 
codon, p.R759X. The CLCN1 variant was absent from the genomes of 127 Labrador Retriever controls and 474 control dogs from other 
breeds. This study expands the spectrum of identified canine CLCN1 mutations and the list of affected breeds in myotonia congenita and 
highlights the potential value of dogs as translational large animal models of human genetic diseases. 
© 2018 The Authors. Published by Elsevier B.V. 
This is an open access article under the CC BY-NC-ND license. ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) 



























Non-dystrophic myotonias are a group of skeletal chan-
elopathies including myotonia congenita and the sodium
hannel myotonias (paramyotonia congenita, potassium- 
ggravated myotonia, hyperkalemic periodic paralysis among 
thers) caused by mutations affecting skeletal muscle ion
hannels ( CLCN1 , chloride voltage-gated channel 1; SCNA4 ,✩ This study was conducted at the Centre for Clinical Veterinary Medicine, 
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Disorders (2018), https://doi.org/10.1016/j.nmd.2018.05.002 odium voltage-gated channel alpha subunit 4) [1] . The non-
ystrophic myotonias are distinguished from the dystrophic
yotonias, which present as multisystem disease with vari-
ble extramuscular manifestations, progressive muscle weak- 
ess, muscle wasting and myotonia [2,3] . 
Myotonia congenita in humans is an inherited skeletal mus-
le ion channel disorder, due to a mutation in the sarcolemmal
oltage-gated chloride channel gene ( CLCN1 ) on chromosome
q35 [4] . More than 100 missense and non-sense mutations,
nsertions, deletions and splice site mutations in CLCN1 have
een identified in humans [1] . Myotonia congenita is char-
cterized by delayed relaxation of muscles after voluntary
ontraction and reflects a state of muscle fiber hyperexcitabil-
ty. In humans, the inheritance is autosomal recessive (Becker
ype, severe) [5] or autosomal dominant (Thomsen type, mild)
6] . Both forms are characterized by muscle stiffness, typi-
ally provoked by gait initiation or sudden movements after
est. Myotonia severity improves after continued activity, thess article under the CC BY-NC-ND license. 
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t  so called “warm-up phenomenon”. Additionally, it presents as
percussion myotonia with prolonged muscle contraction after
mechanical compression (reflex hammer). The recessive form
shows more severe clinical signs, patients experience transient
weakness on initiation of movement and display a more pro-
nounced muscle hypertrophy [5,6] . Electromyography shows
typical myotonic discharges with waxing and waning fre-
quency and amplitude and the characteristic “dive-bomber”
sound on a loudspeaker [7] . 
Myotonia congenita has been extensively studied in goats
[8,9] and thereafter in many other mammalian species in-
cluding horses [10,11] , calf [12] , mice [13] , dogs [14–16] ,
cats [17,18] , Murrah water buffalo [19] and sheep [20] . Like
in humans, myotonia associated mutations were allocated to
CLCN1 in the goat [9] , horse [11] , mice [13] , dog [15,16,21] ,
cat [18] , Murrah water buffalo [19] and sheep [20] . Amongst
canine breeds, myotonia congenita has been described in
Chow-Chows [14] and Miniature Schnauzers [15] and iso-
lated cases have been identified in a Staffordshire terrier
[22] , Great Dane [23] , Cocker Spaniel [24] , Australian Cat-
tle Dog [16] and Jack Russel Terrier [21] . All these breeds
share a common phenotype with clinical myotonia featur-
ing a warm-up phenomenon, electromyographic myotonia,
absence of muscle changes apart from pronounced muscle
hypertrophy. Genetic investigations have discovered variants
in CLCN1 in Miniature Schnauzers and Jack Russel Terriers
( CLCN1 : c.803C > T resulting in p.T268M) [15,21] , the Aus-
tralian Cattle Dogs and Border Collies ( CLCN1 : c.2665insA
resulting in loss of the C-terminal 88 amino acid residues)
[16,25] and cats ( CLCN1 : c.1930 + 1G > T resulting in an al-
tered splice site) [18] . 
We present here a previously unreported myotonia con-
genita in a Labrador Retriever caused by a novel CLCN1
mutation. This study increases the spectrum of genetic my-
opathies in Labrador Retrievers and enables genetic testing as
a diagnostic and breeding tool. 
2. Patients and methods 
2.1. Clinical assessment 
The signalment and history of the puppy were obtained
and a clinical and neurological examination following stan-
dard procedures was performed. Blood was collected via
venous puncture in EDTA, serum and heparinized tubes
and submitted for further analysis. Urine was collected via
cystocentesis. Routine laboratory evaluation included blood
count (leukocytes, erythrocytes, thrombocytes, PCV, differen-
tial count), biochemistry (AP, ALT, creatine kinase, glucose,
BUN, creatinine, sodium, potassium, chloride, calcium, phos-
phate, postprandial ammonia, bile acids, cholesterol, triglyc-
erides), blood gas analysis (pH, HCO 3 −, ionized calcium,
lactate) and urinary analysis (pH, specific gravity, sediment,
protein:creatinine ratio) in an in-house laboratory. Serum was
submitted for type 2M antibodies associated with immune-
mediated masticatory muscle myositis (Neuromuscular Di-Please cite this article as: P.R. Quitt et al., Myotonia congenita in 
Disorders (2018), https://doi.org/10.1016/j.nmd.2018.05.002 gnostic Laboratory, San Diego, USA) and total thyroxine
IDEXX). 
PCR based genetic analysis at a commercial laboratory
Laboklin, Germany) was performed for known disease vari-
nts in Labrador Retrievers: X-linked myotubular myopathy
 MTM1, c.465C > A; exon 7 ) [26] , the SINE exonic inser-
ion mutation in PTPLA associated with centronuclear my-
pathy [27] , and congenital myasthenic syndrome ( COLQ ,
.1010T > C, exon 14) [28] . 
.2. Further investigations 
All subsequent investigations were performed under gen-
ral anesthesia following placement of an intravenous catheter
nto the cephalic vein, premedication with butorphanol (Do-
orex, MSD Animal Health, 0.3 mg/kg) and diazepam (Zia-
am, Ecuphar, 0.3 mg/kg). General anesthesia was induced
ith propofol (Narcofol, Cp-pharma, repeated 1 mg/kg boli)
nd maintained with isoflurane. 
Electromyography (EMG) was performed with standard
lectrodiagnostic equipment (Viking Quest, Natus Europe,
lanegg, Germany) and a concentric needle electrode (record-
ng area 0.07 mm 2 ). All the appendicular and axial skele-
al muscles as well as muscles of the head and tongue
ere explored. Compound muscle action potential, motor
erve conduction velocity and F-waves were evaluated fol-
owing stimulation of the tibial nerve at distal (hock) and
roximal (trochanter) stimulation sites with monopolar nee-
le electrodes. Compound muscle potential was recorded of
he plantar interosseous mm. with surface electrodes placed
n a standard tendon-belly recording [29] . Compound muscle
ction potential was evaluated following single and repetitive
3 Hz) tibial nerve stimulation. 
Radiographs of the cervical spine were performed in a lat-
ral and ventrodorsal position. Magnetic resonance imaging
MRI) of the brain and cervical spine was performed with
 1.5 T MR unit (MAGNETOM Symphony, Siemens, Erlan-
en, Germany) utilizing T2-weighted, pre- and post-contrast
gadodiamide, Omniscan TM , GE Healthcare, 0.3 ml/kg) T1-
eighted and fat suppressed sequences. 
.3. Muscle and nerve biopsies 
Skeletal muscle biopsies were taken from both thoracic
nd pelvic limbs (right biceps brachii, triceps brachii and
astrocnemius muscles). Moreover, a nerve biopsy was ob-
ained from common peroneal nerve. The samples were
hipped fresh to the laboratory for immediate processing.
uscle biopsies were snap-frozen in isopentane cooled in
iquid nitrogen for cryohistology. Further samples were im-
ersed in 10% neutral-buffered formalin for paraffin embed-
ing and in 6.5% glutaraldehyde for semithin histology, on
poxy sections, and electron microscopy. Cryosections were
tained with haematoxylin-eosin (HE), Engel’s modified Go-
ori trichrome stain, oil red O, and periodic acid Schiff
eaction. Moreover, fibre type differentiation was achieved
hrough immunohistochemistry for myosin heavy chain. Fur-a Labrador Retriever with truncated CLCN1 , Neuromuscular 
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i  her slides underwent enzyme histochemistry for COX and
ADH-TR activities. Paraffin sections were stained with HE
nd Goldner’s trichrome stain. 
Semithin sections were stained with toluidine blue-safranin
. Ultrathin sections of 50 nm were performed on selected
reas of two muscles, contrasted with lead citrate and uranyl
cetate and examined through electron microscopy (Zeiss
M10®). 
Complementing respective genetic analyses, immunohis- 
ochemical staining was performed for dystrophin (mouse
nti-dystrophin antibody, Novocastra Reagents) and spectrin
mouse anti-spectrin alpha chain antibody clone AA6, Merck
illipore) in both cryosections and paraffin sections. 
Nerve samples were fixed in 2.5% glutaraldehyde and pro-
essed routinely to enable teased nerve studies and evaluation
f semithin sections [30] . 
.4. Clinical course and treatment response 
Follow-up data were obtained by regular contact to the
og’s owner who provided videos of the gait and repeated
xaminations at LMU Munich. All the clinical examinations
ere performed with the owner’s consent. The owner gave
ritten permission for the scientific use and publication of
ata and multimedia files. 
.5. DNA isolation and whole exome sequencing 
.5.1. Study cohorts 
EDTA-blood samples were collected from the case and
rivately owned dogs in Germany and Finland. The sam-
les were stored at −20 °C until genomic DNA was ex-
racted using the semi-automated Chemagen extraction robot
PerkinElmer Chemagen Technologie GmbH). DNA con-
entration was determined either with the NanoDrop ND-
000 UV/Vis Spectrophotometer or Qubit 3.0 Fluorometer
Thermo Fisher Scientific Inc). A sample collection was eth-
cally approved by the Animal Ethics Committee of the State
rovincial Office of Southern Finland, Hämeenlinna, Finland
ESAVI/7482/04.10.07/2015). 
.5.2. Genetic analyses 
The known variants for congenital neuromuscular dis-
ases in Labrador Retrievers in the PTPLA , MTM1 and
OLQ genes were tested in a commercial laboratory (Labok-
in, Germany). Libraries for whole exome sequencing were
enerated with SeqCap EZ developer design 140702_can- 
am3_exomeplus_BB_EZ_HX1 (Roche) [31] , according to
he manufacturer’s instructions. The sequencing was per-
ormed using Illumina’s NextSeq500 with an average cov-
rage of 68X. The alignment and variant calling has been
escribed earlier [32] . Canine genome build CanFam3.1 was
sed as a reference sequence. Variant filtering was done
ith the assumption of a recessive mode of inheritance and
he variants from the case dog were filtered against vari-
nts in 268 available unaffected control dogs (Supplemen-
ary Table 1). The presence of the candidate causative vari-Please cite this article as: P.R. Quitt et al., Myotonia congenita in 
Disorders (2018), https://doi.org/10.1016/j.nmd.2018.05.002 nt was further screened in the whole genome sequencing
ata available from 39 unaffected Labrador Retrievers and
29 other dogs from 63 breeds (Supplementary Table 1).
dditional 88 unaffected Labrador Retrievers were geno-
yped by PCR and Sanger sequencing with the following
orward 5 ′ -CCAGTTCTTAGAGGCATGCC-3 ′ and reverse 5 ′ -
GGTGTCTATGGAGGTGGAG-3 ′ primers. The genotype of 
he case dog was confirmed by Sanger sequencing. 
. Results 
.1. Clinical presentation 
An 8-week-old male Labrador Retriever puppy was pre-
ented with a history of intermittent stiff-legged robotic gait
nd straight-legged stance which was noted soon after the
uppy became ambulatory. Additionally, excitement-induced 
pper airway stridor and difficulties swallowing liquids and
ood were reported. The dog was rescued from poor housing
onditions and a detailed patient history was not available.
bnormal findings on physical examination included weak
losure of the jaw, hypertrophy of the tongue ( Fig. 1 A) and
ontinuous wheezing sounds, which worsened with excite-
ent and manual compression of the larynx. The puppy dis-
layed marked stiff-stilted gait in all four limbs with a de-
reased ability to flex the joints which was most evident after
 short period of rest. When excited the puppy would start
alking with a bunny hopping gait of the pelvic limbs for
he first two to three steps. The gait improved and stiffness
ubsided with prolonged continued activity. This was con-
idered a “warm-up phenomenon” typical for myotonia con-
enita (Videos S1 and S2). Percussion of the cranial tibial
uscle with a reflex hammer elicited a sustained dimpling of
he muscle and flexion of the hock for several seconds (Video
3). Mild discomfort was elicited at palpation of the dor-
al neck, most pronounced at the level of the atlantooccipital
oint. When fed dry dog food (kibbles), the puppy struggled
o move the treat backwards with its tongue which appeared
ontracted for several seconds (Video S4). The neurologic ex-
mination was otherwise normal. Besides a mild increase in
reatine kinase activity (697 U/l; reference range 54–348 U/l)
he laboratory evaluation was unremarkable. Type 2 M anti-
odies were absent and thyroxine hormone concentration was
ithin the reference range of the laboratory. A few weeks
ater the owner reported that the puppy experienced collaps-
ng episodes which were induced by violent playful activity
Video S5). Provided video sequences showed episodes with
igidity of the whole body and stiff extended limbs. After a
all on the ground the puppy remained in lateral recumbency
ith all four limbs extended, not able to move for several
econds. The dog recovered rapidly and returned to ambula-
ion. 
.2. Electromyography and magnetic resonance imaging 
Electromyography identified prolonged insertional activ- 
ty followed by abundant myotonic discharges in all mus-a Labrador Retriever with truncated CLCN1 , Neuromuscular 
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Fig. 1. Labrador Retriever with myotonia congenita. (A) Hypertrophy of the tongue, (B) normal appearance of the head, (C,D) severe hypertrophy of the neck 





















































b  cles with characteristic waxing and waning amplitudes in the
anesthetized dog. The generated sound from these discharges
on the EMG loudspeaker resembled a “dive bomber” sound.
Myotonic discharges were best identified when displayed at
higher sweep speeds (Video S6). Sciatic-tibial motor nerve
conduction velocity (51 m/s) and repetitive tibial nerve stim-
ulation at 3 Hz (no decrement or increment) were considered
unremarkable for the age of the dog. Compound muscle action
potential (recorded from the interosseous muscles with surface
electrodes) was of normal amplitude and duration without any
evidence of temporal dispersion. 
Further investigations with MRI and radiographs failed to
identify an underlying cause for the mild cervical pain be-
sides mild atlantooccipital joint effusion and synovial con-
trast enhancement. All muscles appeared with normal signal
intensity. 
3.3. Muscle and nerve findings 
Epimysium, perimysium and endomysial connective tis-
sue, including blood vessels and intramuscular nerve twigs,
were unremarkable. Myofibre density was within normal lim-
its ( Fig. 2 A). Fibre diameters displayed variations featuring
isolated or clustered small polygonal fibres ( Fig. 2 B–D, white
asterisks) intermingling with mildly hypertrophic round non-
lobulated myofibres ( Fig. 2 B–D, black asterisks). The my-
ofibrillar pattern was preserved ( Fig. 2 B–D). Mitochondrial
distribution and enzyme reactivities ( Fig. 2 B,C) were within
a physiological range. The number of myonuclei was within
normal limits but nuclear internalization was occasionallyPlease cite this article as: P.R. Quitt et al., Myotonia congenita in 
Disorders (2018), https://doi.org/10.1016/j.nmd.2018.05.002 een ( Fig. 2 D). Some fibres showed a mild increase in in-
erfibrillar fat droplets ( Fig. 2 D). Myofibre typing revealed
0% type 1 and 50% type 2 myofibres. Immunohistochem-
stry for dystrophin and spectrin showed continuous sarcolem-
al staining pattern in both cryo- and paraffin sections. Trans-
ission electron microscopy revealed a normal ultrastructure
f myofibres, blood vessels and intramuscular nerve endings.
o pathological changes were seen in the peripheral nerve
pecimen. Degree of myelination was in accordance with the
ge ( Fig. 2 E). 
.4. Clinical course and treatment response 
Myotonia congenita was considered based on clinical
igns, electromyographic myotonia and unremarkable mus-
le histology. Treatment with mexiletine hydrochloride at
 mg/kg BID titrated up to 8 mg/kg BID (Novo-Mexiletine,
ovopharm, Toronto, Canada) was initiated and has contin-
ed up to now. No side effects of the medication were noted
nd an electrocardiogram (after 2 months) was unremarkable.
he owner reported the dog’s improved ability to move the
ongue and swallow food and less inspiratory noises were
oticed. Initiation of movement appeared also improved, but
uscle stiffness and abnormal gait after rest were still evi-
ent and collapsing episodes did not cease. Stiffness appeared
orse on outdoor walks on cold days during the winter. Over
he course of the following 12 months the puppy developed an
mpressive generalized muscle hypertrophy, most pronounced
n the neck and proximal appendicular muscles of all limbs,
ut the appearance of the head remained normal ( Fig. 1 B–F).a Labrador Retriever with truncated CLCN1 , Neuromuscular 
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Fig. 2. Overview of muscle (A–D) and nerve (E) findings on cryosections (A–C) and semithin histology (D,E). Low power field examination of the muscle 
on HE as well as reactivities of cytochrome oxidase (B) and NADH-TR (C) show subsignificant changes. On close examination there are mild bimodal fibre 
size variations (B–D, asterisks). No changes are seen in nerve sections (E). 

















































o  .5. Genetic analyses 
Since the known neuromuscular disease variants in the
TM1 [26] , PTPLA [27] and COLQ [28] genes were
xcluded in the affected dog, a whole exome sequencing was
erformed to identify the causative gene and variant. The vari-
nt data from the case dog were filtered against 268 unaf-
ected dogs (Supplementary Table 1), resulting in the iden-
ification of six case-specific coding variants (Supplementary
able 2) of which the nonsense variant in CLCN1 appeared
ost likely causative, since this gene has been previously
ssociated with myotonia in dogs and humans. A homozy-
ous nonsense variant in exon 19 (out of 23) of the CLCN1
ene, c.2275A > T leads to a premature stop codon, p.R759X
 Fig. 3 ). The CLCN1 variant was absent from the genomes of
dditional unaffected 127 Labrador Retrievers and 474 control
ogs. Exome sequencing data is available at Sequence Read
rchive (SRA) under study accession SRP139271. 
. Discussion 
This study describes a novel CLCN1 -associated myotonia
ongenita in an 8-week-old Labrador Retriever. The family
istory of the affected Labrador Retriever puppy was un-
nown and samples from the parents and the siblings were
ot available for genetic analysis. Population screening failedPlease cite this article as: P.R. Quitt et al., Myotonia congenita in 
Disorders (2018), https://doi.org/10.1016/j.nmd.2018.05.002 o identify any carriers. Thus, we cannot exclude a possibility
f a de novo mutation in this puppy. 
This study enhances the spectrum of congenital myopathies
eported in Labrador Retrievers. Labrador Retrievers are
ffected by various types of rare genetic myopathies with
verlapping clinical features, including X-linked myotubu- 
ar myopathy ( MTM1 ) [26] , Duchenne muscular dystrophy
 DMD ) [33] , centronuclear myopathy ( PTPLA ) [27] , congen-
tal myasthenic syndrome ( COLQ ) [28] and myotonia con-
enita ( CLCN1 ) described here. The genetic basis remains
o be identified for a mild muscular dystrophy [34] and
arcolemmal-specific collagen VI deficient myopathy in the
abrador Retriever [35] , which has been attributed to COL6A1
n Landseer dogs [36] . In Labrador Retrievers, electrical my-
tonia is also a feature of centronuclear myopathy [37] . Elec-
romyographic myotonia was described in incidental cases of
yotonic dystrophy in other dog breeds (Boxer, Rhodesian
idgeback) [38,39] and with various toxins, metabolic and
ndefined myopathies [40] . The clinical signs in this Labrador
etriever with myotonia congenita are also reminiscent of two
reviously described movement disorders in Labrador Retriev-
rs: familial reflex myoclonus (hyperekplexia, startle disease)
nd hypertonicity syndrome with extreme generalized mus-
le stiffness [41,42] . Electromyography failed to identify any
yotonic discharges in the anesthetized dogs therefore my-
tonia congenita was excluded from both disorders. Despitea Labrador Retriever with truncated CLCN1 , Neuromuscular 
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Fig. 3. Whole exome sequencing of a case dog revealed a homozygous nonsense variant (A) (c.2275A > T) in exon 19, resulting in a premature stop codon 




















































S  the fact that the CLCN1 variant found here was present only
in one dog, the genetic test that can be developed will assist
the differential diagnosis of clinically similar myopathies in
the breed. 
In the present case myotonia congenita was diagnosed
based on characteristic clinical signs: muscle stiffness after
rest, collapse provoked by sudden movements and abundant
myotonic discharges with a typical waxing and waning pat-
tern in the anesthetized dog. The observed clinical signs,
stiff “robotic gait”, which improved with continued activity,
transient immobility on initiation of sudden movements and
prominent muscle hypertrophy are identical to other reports of
myotonia congenita in dogs and humans [1,14–16,21] . Mus-
cle and nerve biopsies and MRI primarily served to exclude
myotonic dystrophies and other myopathies. Thus the diag-
nosis of myotonia congenita relied solely on demonstration
of clinical and electromyographic myotonia and genetic find-
ings. Brachygnathia and other craniofacial and dental abnor-
malities were described in other dogs with myotonia con-
genita, but were not seen in the Labrador Retriever [16,43] .
Oropharyngeal dysphagia was the presenting complaint and
was attributed to spasms of tongue and pharyngeal muscles
and hypertrophy of the tongue. Oropharyngeal dysphagia is
a frequent and often fatal complication of many congeni-
tal and acquired myopathies in humans and dogs [26,39,44–
48] . Swallowing problems, stridor and decreased tongue mo-
bility were described in the Miniature Schnauzer and catsPlease cite this article as: P.R. Quitt et al., Myotonia congenita in 
Disorders (2018), https://doi.org/10.1016/j.nmd.2018.05.002 ith myotonia congenita [40,18] and oropharyngeal dyspha-
ia was the initial clinical sign in a Rhodesian Ridgeback with
ystrophic myotonia [39] . This study provides further evi-
ence that myotonia congenita should be considered as a
ossible cause for dysphagia and swallowing problems in pup-
ies and that electromyography, muscle biopsies and genetic
nvestigations are indicated. Genetic testing for known muta-
ions and possibly also sequencing of the candidate CLCN1
or new variants may be a convenient option for first line
iagnostics for future suspected cases of myotonia congenita.
Specific treatment acting on the chloride channel is not
vailable. Therefore, treatment of myotonia congenita aims
o modulate the sodium channels to decrease the excitabil-
ty of the muscle membrane. Mexiletine hydrochloride is the
rst-line treatment. Efficacy and side effects of other antiar-
hythmic agents, antiepileptic drugs, antidepressants, calcium
hannel blockers, diuretics and amino acids have been ex-
lored [1,49] . Class 1 antiarrythmic drugs such as mexile-
ine and procainamide have both been used successfully in
he management of myotonia congenita in people and dogs
3,49,50] . Oral application of mexiletine hydrochloride was
ell tolerated by the Labrador Retriever. The owner reported
he dog’s improved ability to move the tongue and swallow
ood with less inspiratory noises, but collapsing episodes and
uscle stiffness were still observed.. The veterinary litera-
ure describes treatment of myotonia congenita in a Miniature
chnauzer with mexiletine 8.3 mg/kg every 8 h, resulting ina Labrador Retriever with truncated CLCN1 , Neuromuscular 
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mprovement of clinical signs [40] . A similar effect was seen
ith procainamide 40 mg/kg every 6 h, but higher dosages
roduced weakness and lethargy [51] . Extended-release
rocainamide 40–50 mg/kg every 8–12 h reduced clinical
yotonia [40] . In Chow-Chow puppies quinidine and pheny-
oin alleviated myotonia, but procainamide showed the better
ffect [14,40] . Recently a randomized, double-blind, placebo-
ontrolled study with lamotrigine (sodium channel blocker)
howed effective reduction of myotonia in genetically con-
rmed myotonia congenita and paramyotonia congenita in
umans [52] . Cardiotoxicity limits the use of lamotrigine in
ogs [53] . 
Dogs represent an important translational animal model for
reclinical studies evaluating new treatment modalities for
ongenital myopathies. Recent studies highlight the success
f gene therapy in Golden Retriever muscular dystrophy and
abrador Retriever X-linked myotubular myopathy [54,55] .
his study demonstrates the value of a joint clinical and
olecular genetics approach with whole exome sequencing
or the molecular diagnosis of genetic neuromuscular diseases
n dogs. 
. Conclusion 
Several genetic myopathies with overlapping clinical fea-
ures have been reported in Labrador Retrievers. We describe
 novel mutation in CLCN1 causing myotonia congenita in
he breed which can be included in future panel diagnostics
or genetic myopathies in this dog breed. Genetic testing will
ffer a feasible approach for differential diagnosis in neu-
omuscular disorders particularly when myotonia congenita 
s suspected based on neurolocalization, phenomenology and
MG. 
Video S1 Gait of the Labrador Retriever puppy 
The Labrador Retriever puppy displayed marked stiff-
tilted gait in all limbs which was most evident after a short
eriod of rest. When excited the puppy would start walking
ith a bunny hopping gait of the pelvic limbs for the first
wo to three steps. The gait improved and stiffness subsided
ith prolonged continued activity consistent with a “warm-up
henomenon” typical for myotonia congenita. 
Video S2 Gait of the adult dog 
The one-year-old Labrador Retriever shows stiff gait on
he initiation of movements. The gait improves with continued
ctivity (“warm-up phenomenon”). 
Video S3 Percussion myotonia 
Percussion of the cranial tibial muscle with a reflex ham-
er elicited a dimpling of the muscle and sustained contrac-
ion of the muscle. 
Video S4 Oropharyngeal dysphagia 
When feeding dry dog food (kibbles), the puppy struggles
o move the food backwards with the tongue. The second
art of the video shows problems with the uptake of water
nd repeated swallowing efforts. 
Video S5 Collapsing episodes 
The three-month-old puppy experienced collapsing 
pisodes, which were induced by violent playful activ-Please cite this article as: P.R. Quitt et al., Myotonia congenita in 
Disorders (2018), https://doi.org/10.1016/j.nmd.2018.05.002 ty. Video sequences show episodes with rigidity of the
hole body and stiff extended limbs. After a fall on the
round the puppy remained in lateral recumbency with all
our limbs extended and was not able to move for a few
econds. The second part of the video shows the one-year-old
abrador Retriever collapsing for few seconds when initiating
 sudden movement and a quick change of direction. 
Video S6 Myotonic discharges 
Electromyography identified prolonged insertional activity 
ollowed by abundant myotonic discharges in all muscles with
haracteristic waxing and waning amplitudes. The generated
ound resembled a “dive bomber” appearance. Myotonic dis-
harges were best identified when displayed at higher sweep
peeds. 
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